These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16130417)

  • 21. Multidrug resistant tuberculosis.
    Amdekar YK
    Indian Pediatr; 1998 Aug; 35(8):715-8. PubMed ID: 10216564
    [No Abstract]   [Full Text] [Related]  

  • 22. New generation methods for drug susceptibility testing for tuberculosis.
    Katoch VM
    Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
    [No Abstract]   [Full Text] [Related]  

  • 23. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
    Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
    Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of rifampicin-resistant intraocular tuberculosis.
    Sharma K; Bansal R; Sharma A; Gupta A; Fiorella PD
    Ocul Immunol Inflamm; 2015 Feb; 23(1):93-6. PubMed ID: 24654625
    [No Abstract]   [Full Text] [Related]  

  • 27. [Problem of drug-resistant tuberculosis and the way of its solution].
    Pukhlik BM
    Probl Tuberk; 1999; (6):17-20. PubMed ID: 10715949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey.
    Talay F; Kumbetli S; Altin S
    Jpn J Infect Dis; 2008 Jan; 61(1):25-30. PubMed ID: 18219130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).
    N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V
    Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272
    [No Abstract]   [Full Text] [Related]  

  • 30. The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population.
    Bifani P; Mathema B; Kurepina N; Shashkina E; Bertout J; Blanchis AS; Moghazeh S; Driscoll J; Gicquel B; Frothingham R; Kreiswirth BN
    J Infect Dis; 2008 Jul; 198(1):90-4. PubMed ID: 18498237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
    Umubyeyi AN; Rigouts L; Shamputa IC; Fissette K; Elkrim Y; de Rijk PW; Struelens MJ; Portaels F
    J Antimicrob Chemother; 2007 May; 59(5):1031-3. PubMed ID: 17329272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug resistance in tuberculosis--a reinfection model.
    Rodrigues P; Gomes MG; Rebelo C
    Theor Popul Biol; 2007 Mar; 71(2):196-212. PubMed ID: 17174368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of risk factors of the occurrence of drug resistance in patients with tuberculosis from civil and penitentiary sectors in the Samara Region].
    Balabanova IaM; Raddi M; Gram K; Malomanova NA; Elizarova ED; Kuznetsov SI; Gusarova GI; Zakharova SM; Melent'ev AS; Kriukova EG; Fedorin IM; Golyshevskaia VI; Dorozhkova IR; Shilova MV; Erokhin VV; Drobnevskiĭ F
    Probl Tuberk Bolezn Legk; 2005; (5):25-31. PubMed ID: 15988974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia.
    Baranov AA; Mariandyshev AO; Mannsåker T; Dahle UR; Bjune GA
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1288-93. PubMed ID: 19793435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
    Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
    J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular biological assays in phthisiology].
    Skotnikova OI
    Probl Tuberk Bolezn Legk; 2005; (8):5-10. PubMed ID: 16209010
    [No Abstract]   [Full Text] [Related]  

  • 39. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of multidrug resistance in Mycobacterium tuberculosis.
    Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
    J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.